Biodefense Market worth $1.81 billion by 2030 - Exclusive Report by MarketsandMarkets™

The Biodefense Market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period. The growth of the Biodefense Industry is propelled by a combination of global awareness of biological threats, increased government spending on national security, and the rapid advancement of detection and decontamination technologies.

Market Size & Forecast
• 2024 Market Size (Value): USD 0.89 Billion
• 2030 Market Forecast (Value): USD 1.81 Billion
• CAGR: 15.1% from 2025–2030
• Asia Pacific: Fastest-Growing Region
• Driver: Rising Threat of Bioterrorism

KEY TAKEAWAYS
The market is segmented into detection & surveillance, decontamination systems, and others, based on product type. The increasing threat of emerging infectious diseases and bioterrorism will drive the detection & surveillance segment. Growing investment in sterilization and disinfection units across defense and healthcare facilities is driving the growth of the decontamination systems segment.
UV-based, cold plasma, and AI-driven biosensor technologies are emerging as the most disruptive tools in biodefense. Advancements in GHz-band and RF-EMR heating systems are enhancing the speed and efficiency of pathogen inactivation in biodefense applications.
Military and hospitals/medical institutes remain dominant adopters, while homeland security and public infrastructure drive steady civilian demand. Hospitals, medical institutes, and public infrastructure are focusing on increasing demand for decontamination and biosurveillance solutions.
The Asia Pacific is projected to be the fastest-growing region in the global biodefense market, with a CAGR of 17.0% with significant investments in biodefense infrastructure and R&D, including the development of advanced surveillance systems and protective equipment. North America also maintains dominance due to robust funding from agencies like BARDA and DHS for biosurveillance and biocontainment infrastructure.
Major players in the biodefense market have adopted both organic and inorganic strategies, including partnerships and investments. In February 2025, Thermo Fisher Scientific announced the acquisition of Solventum’s Purification and Filtration business for USD 1.5 billion in cash. In September 2024, Synexis announced a strategic partnership with Diversey, a global leader in hygiene and infection prevention solutions, to expand the reach of its Dry Hydrogen Peroxide (DHP) technology.
The growth of the Biodefense Market will be fueled by the increasing risk of bioterrorism and the emergence of infectious diseases. Key enablers include increased government funding, innovation in detection & surveillance, particularly AI-driven tools and biosensors, as well as stronger global coordination in health security infrastructure.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The impact on consumers’ business emerges from customer trends or disruptions. Trends and disruptions impacting customer businesses often stem from the growing demand for biosurveillance and technological advancements that drive the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119088131
read more..